In a scathing and precedent-setting ruling against Discovery Health Medical Scheme, the industry regulator has opened the door for consumers to force the industry to pay for treatment not available in state hospitals.

The Council for Medical Schemes’s (CMS’s) ruling follows a case by an eye-disease glaucoma patient, who took the scheme, which is administered by financial services group Discovery’s health insurance arm, on after it refused to pay for an implant of a medicated device called a Xen stent to lower eye pressure as recommended by a specialist...

Subscribe now to unlock this article.

Support BusinessLIVE’s award-winning journalism for R129 per month (digital access only).

There’s never been a more important time to support independent journalism in SA. Our subscription packages now offer an ad-free experience for readers.

Cancel anytime.

Would you like to comment on this article?
Sign up (it's quick and free) or sign in now.

Speech Bubbles

Please read our Comment Policy before commenting.